Correlation Between Diamyd Medical and FORMPIPE SOFTWARE

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Diamyd Medical and FORMPIPE SOFTWARE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diamyd Medical and FORMPIPE SOFTWARE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Diamyd Medical AB and FORMPIPE SOFTWARE AB, you can compare the effects of market volatilities on Diamyd Medical and FORMPIPE SOFTWARE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diamyd Medical with a short position of FORMPIPE SOFTWARE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diamyd Medical and FORMPIPE SOFTWARE.

Diversification Opportunities for Diamyd Medical and FORMPIPE SOFTWARE

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between Diamyd and FORMPIPE is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Diamyd Medical AB and FORMPIPE SOFTWARE AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FORMPIPE SOFTWARE and Diamyd Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diamyd Medical AB are associated (or correlated) with FORMPIPE SOFTWARE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FORMPIPE SOFTWARE has no effect on the direction of Diamyd Medical i.e., Diamyd Medical and FORMPIPE SOFTWARE go up and down completely randomly.

Pair Corralation between Diamyd Medical and FORMPIPE SOFTWARE

Assuming the 90 days horizon Diamyd Medical is expected to generate 1.54 times less return on investment than FORMPIPE SOFTWARE. In addition to that, Diamyd Medical is 1.39 times more volatile than FORMPIPE SOFTWARE AB. It trades about 0.09 of its total potential returns per unit of risk. FORMPIPE SOFTWARE AB is currently generating about 0.19 per unit of volatility. If you would invest  188.00  in FORMPIPE SOFTWARE AB on September 4, 2024 and sell it today you would earn a total of  24.00  from holding FORMPIPE SOFTWARE AB or generate 12.77% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Diamyd Medical AB  vs.  FORMPIPE SOFTWARE AB

 Performance 
       Timeline  
Diamyd Medical AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Diamyd Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
FORMPIPE SOFTWARE 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in FORMPIPE SOFTWARE AB are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating basic indicators, FORMPIPE SOFTWARE may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Diamyd Medical and FORMPIPE SOFTWARE Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Diamyd Medical and FORMPIPE SOFTWARE

The main advantage of trading using opposite Diamyd Medical and FORMPIPE SOFTWARE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diamyd Medical position performs unexpectedly, FORMPIPE SOFTWARE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FORMPIPE SOFTWARE will offset losses from the drop in FORMPIPE SOFTWARE's long position.
The idea behind Diamyd Medical AB and FORMPIPE SOFTWARE AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk